Psoriasis Treatment Market Research Report By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Biologics), By Administration Route (Oral, Topical, Injectable, Intravenous), By Indication (Plaque Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Pustular Psoriasis), By End User (Hospital, Dermatology Clinics, Homecare Settings) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

Global Psoriasis Treatment Market Overview

As per MRFR analysis, the Psoriasis Treatment Market Size was estimated at 7.14 (USD Billion) in 2023.The Psoriasis Treatment Market Industry is expected to grow from 7.45(USD Billion) in 2024 to 12 (USD Billion) by 2035. The Psoriasis Treatment Market CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2035).

Key Psoriasis Treatment Market Trends Highlighted

The Psoriasis Treatment market is growing due to key market drivers within it. This growth is due to the increasing awareness concerning psoriasis which, along with its prevalence in numerous regions, prompts the demand for effective treatment options. Moreover, newer therapies are being developed and becoming more accessible due to improvements in biotechnology and pharmacology. There has been a change in treatment approaches, as moderate to severe cases of psoriasis are now treated using Biologics and targeted therapies, which are more effective and gaining greater popularity than before. With new developments in telehealth and other digital health solutions, there is a greater focus on caring for the patients, which has uncovered new opportunities for the market.

This development enables more efficient patient management and treatment adherence, improving results for patients with psoriasis. Furthermore, recent partnerships between pharmaceutical companies and health care providers focus on developing new research and treatment solutions, leveraging networked care to fulfill existing medical gaps. Regarding new developments, there has been a marked increase in attention and funding directed toward psoriasis research, particularly in exploring the disease and its comorbidities. The increase in skin health dietary supplements and natural treatment approaches is expanding as more patients look for alternative ways to cope with their disease.

The international scope of the market implies that policy makers and regulatory bodies in different areas of the world are also influencing the treatment landscape, promising more active innovative therapy development while ensuring patient safety. All in all, these trends demonstrate a responsive and proactive market geared toward addressing the needs of patients and health care practitioners across the globe.

 

Psoriasis Treatment Market Drivers

Increasing Prevalence of Psoriasis

The Global Psoriasis Treatment Market Industry is significantly driven by the rising prevalence of psoriasis globally. According to various data from healthcare reports, it is estimated that psoriasis affects around 2% to 3% of the world's population, translating to approximately 125 million individuals. Organizations like the World Health Organization (WHO) highlight the growing burden of skin diseases, indicating a notable increase in cases over the past decade.As the demand for effective treatments increases, pharmaceutical companies are investing heavily in Research and Development (R) for innovative therapies. 

This trend is expected to boost market growth substantially, as more patients seek advanced treatment options. Key players such as Amgen, JohnsonJohnson, and AbbVie are at the forefront, developing targeted therapies and biologics that cater to this expanding patient base, thus impacting the Global Psoriasis Treatment Market positively.

Advancements in Treatment Options

The development of biologics and novel therapies represents a significant driver in the Global Psoriasis Treatment Market Industry. Recent advancements have led to the creation of targeted therapies that are more effective and have fewer side effects than traditional treatments. For instance, therapies targeting specific pathways involved in the inflammatory process have been introduced, allowing for more personalized treatment approaches. 

The introduction of new biologics, guided by studies from established pharmaceutical companies like Novartis and Eli Lilly, has shown to improve outcomes for patients significantly.With the growing number of treatment options, patients are likely to opt for therapies that offer better efficacy, further stimulating market growth.

Rising Healthcare Expenditure

Globally, the increase in healthcare expenditure is propelling the Global Psoriasis Treatment Market Industry forward. According to data from the World Bank, global health expenditure has risen consistently, reaching about 10% of global GDP in recent years. This surge in spending allows for better access to innovative treatments and advanced medical technologies for psoriasis. As countries prioritize healthcare improvements, patients benefit from more affordable treatment options, enhancing their willingness to seek medical help.Furthermore, organizations such as the Global Psoriasis Coalition advocate for better healthcare policies and insurance coverage, which positively influences market accessibility and growth.

Growing Awareness and Education on Psoriasis

Increased awareness and education regarding psoriasis are significant drivers for the Global Psoriasis Treatment Market Industry. Initiatives by organizations like the National Psoriasis Foundation work worldwide to raise awareness about the disease, its impacts, and the importance of seeking treatment. Educational campaigns have reached millions, illustrating the significance of proper treatment and management of psoriasis. 

As more individuals become aware of available treatments and the need for management, the likelihood of seeking therapy rises.This growing awareness contributes to higher diagnosis rates and engagement with healthcare providers, directly impacting product demand within the Global Psoriasis Treatment Market.

Psoriasis Treatment Market Segment Insights

Psoriasis Treatment Market Treatment Type Insights

The Global Psoriasis Treatment Market exhibits significant growth within the Treatment Type segment, where the valuations for various treatment methods highlight the diverse approaches to managing this chronic skin condition. In 2024, the Global Psoriasis Treatment Market revenue reach approximately 7.45 USD Billion, with substantial contributions from its various treatment categories. As an effective measure for mild to moderate psoriasis, Topical Treatments are valued at 2.0 USD Billion in 2024 and projected to rise to 3.2 USD Billion by 2035, indicating consistency in their demand due to their accessibility and ease of use.

Systemic Treatments, which are often reserved for more severe cases, represent a notable segment as well, beginning at a valuation of 1.8 USD Billion in 2024 and expected to grow to 3.0 USD Billion by 2035. The effectiveness of these treatments in providing relief from more intense symptoms contributes to their importance in the market. Phototherapy, another essential treatment option, is valued at 1.0 USD Billion in 2024 with expectations to double this value to 2.0 USD Billion by 2035, reflecting its role as a viable treatment for patients who prefer non-pharmaceutical options or require combination therapies.Biologics lead this market segment with a projection starting value of 2.65 USD Billion in 2024, increasing to 3.8 USD Billion by 2035; this category's biologic drugs showcase remarkable efficacy in targeting specific pathways in immune response, thereby offering significant benefits for moderate to severe psoriasis patients. 

The contribution of biologics in terms of innovation and effectiveness places them at the forefront of the Global Psoriasis Treatment Market, emphasizing their growing significance as advanced treatment options. The market growth driven by research and development efforts, along with increasing awareness about psoriasis, presents ample opportunities for further segment expansion.Increasing prevalence rates globally highlight the necessity for diversified treatment options and validate the continuing investment in these segments. 

Challenges such as treatment adherence, cost of biologics, and emerging market competition require strategic adjustments to optimize the Global Psoriasis Treatment Market growth trajectory. Overall, the Treatment Type segmentation illustrates a robust landscape where Topical Treatments, Systemic Treatments, Phototherapy, and Biologics collectively shape the future of psoriasis management.

Psoriasis Treatment Market Administration Route Insights

The Administration Route segment of the Global Psoriasis Treatment Market plays a crucial role in determining how therapies are delivered to patients suffering from this chronic skin condition. As the Global Psoriasis Treatment Market revenue is expected to reach 7.45 billion USD , the market is largely driven by the efficiency and convenience of various administration routes. Among the different methods, topical treatments are widely adopted due to their ease of use and direct application to affected areas, making them particularly significant in managing mild to moderate psoriasis.

Oral therapies are also gaining traction, primarily for their systemic effect and patient preference for non-invasive treatment options. Injectable therapies, often considered for more severe cases, offer rapid action and potent effects, while intravenous administration is utilized for patients requiring immediate therapeutic interventions. The choice of administration routes is influenced by factors such as patient compliance, the severity of the disease, and the healthcare setting, contributing to the overall market growth and dynamics. 

As the Global Psoriasis Treatment Market statistics show, these varied routes facilitate better management and enhance patient outcomes, indicating a healthy evolution in treatment approaches.

Psoriasis Treatment Market Indication Insights

The Global Psoriasis Treatment Market valued at 7.45 USD Billion in 2024, with a significant emphasis on the various indicatives of psoriasis. This market comprises diverse types of psoriasis, including Plaque, Guttate, Inverse, and Pustular Psoriasis, each representing distinct manifestations of the condition. Plaque Psoriasis, being the most prevalent form, dominates the market due to its widespread occurrence and the chronic nature that requires ongoing treatment intervention. 

Guttate Psoriasis is another notable form often triggered by infections, making it significant in market consideration as it presents unique treatment challenges.Inverse Psoriasis, characterized by red, shiny lesions in skin folds, showcases a crucial segment due to its specific management needs. Pustular Psoriasis, though less common, highlights the necessity for targeted therapies, further shaping the market landscape. 

The growth of the Global Psoriasis Treatment Market is propelled by advancements in treatment modalities and an increasing focus on patient-centered care, providing abundant opportunities for stakeholders to innovate while addressing pressing challenges. With diverse segments addressing varied patient profiles, the market is poised for evolution, driven by ongoing Research and Development efforts.

Psoriasis Treatment Market End User Insights

The Global Psoriasis Treatment Market is poised for notable growth, expected to reach a valuation of 7.45 USD Billion . This market's segmentation includes critical areas such as hospitals, dermatology clinics, and homecare settings, with each playing a vital role in patient care. Hospitals serve a high volume of patients requiring advanced treatment options, making them a dominant force within the market. Dermatology clinics provide specialized care, leading to tailored treatments for individuals, thereby enhancing the effectiveness of therapies selected for specific patient needs.

Homecare settings are increasingly significant due to their convenience and the rising patient preference for treatments that can be administered in their own environments, significantly impacting patient adherence. The Global Psoriasis Treatment Market data reflects ongoing trends towards personalized medicine and the expanding role of telemedicine, providing opportunities to enhance care access. Furthermore, the aging global population, increasing incidence of psoriasis, and ongoing Research and Development efforts are fundamental growth drivers throughout this market.

However, challenges such as treatment costs and patient access remain pertinent as market stakeholders navigate the evolving healthcare landscape. Understanding these segments and their interdependencies is essential for leveraging existing opportunities and addressing challenges in the Global Psoriasis Treatment Market industry.

Psoriasis Treatment Market Regional Insights

The Global Psoriasis Treatment Market showcases significant regional diversity with North America dominating the landscape. In 2024, North America holds a valuation of 2.85 USD Billion, growing to 4.5 USD Billion by 2035, marking it as a substantial contributor to the market growth. Europe follows closely, with a valuation of 2.25 USD Billion in 2024 and projected to reach 3.5 USD Billion by 2035, indicating a strong market presence. The Asia-Pacific (APAC) region is also noteworthy, valued at 1.75 USD Billion in 2024, with expectations to rise to 2.5 USD Billion in 2035, reflecting growing demand for psoriasis treatment options in emerging markets.

South America, though smaller, is on an upward trajectory with a value of 0.45 USD Billion in 2024, anticipated to grow to 0.7 USD Billion by 2035. The Middle East and Africa (MEA) region currently holds a value of 0.15 USD Billion in 2024, expected to double by 2035, showing gradual market development. Factors supporting this regional segmentation include increasing healthcare access, rising prevalence of psoriasis, and a growing awareness of treatment options among consumers. 

Each region's unique healthcare infrastructure and market needs present distinct opportunities for growth in the Global Psoriasis Treatment Market.The varied market statistics across regions underscore the importance of targeting specific regional strategies to optimize outreach and product availability.

Psoriasis Treatment Market Key Players and Competitive Insights

The Global Psoriasis Treatment Market has become increasingly competitive, driven by the rising prevalence of psoriasis and growing awareness among healthcare providers and patients about the effectiveness of various treatment options. The market has seen a surge in the development of innovative therapies, including biologics, systemic treatments, and topical applications, aimed at providing effective relief for patients suffering from this chronic skin condition. 

Competition among key players in this market is characterized by the continuous introduction of novel products, strategic partnerships, and aggressive marketing strategies to capture larger market shares. The dynamic nature of the industry is further influenced by advancements in research and technology, which have enabled faster identification and targeting of new therapeutic pathways, ultimately benefiting patients looking for improved treatment modalities.

Pfizer has established a strong presence in the Global Psoriasis Treatment Market through its innovative treatment options that address the diverse needs of psoriasis patients. The company has successfully leveraged its research capabilities to develop effective biologics that have gained significant traction in the market. Pfizer's strengths lie in its extensive portfolio, robust clinical data supporting its products, and a dedicated focus on improving patient outcomes. The company's commitment to ongoing research and development ensures the continuous evolution of its treatment offerings, allowing it to respond effectively to the changing market dynamics and patient requirements. Pfizer's strategic collaborations and partnerships further bolster its market position, allowing for streamlined distribution and enhanced market access across various regions.

Merck and Co has made significant inroads into the Global Psoriasis Treatment Market, recognized for its innovative therapies designed to tackle the challenges associated with this skin disease. The company boasts an impressive lineup of key products that include both biologics and oral medications specifically tailored for psoriasis treatment. Merck and Co's strengths stem from its strong research foundation and ongoing focus on clinical trials that demonstrate the efficacy and safety of its products. The company's ability to adapt to changing market conditions is evident in its strategic mergers and acquisitions that bolster its product portfolio and enhance its market footprint. 

These efforts, combined with its relentless commitment to patient-centric approaches, have positioned Merck and Co as a formidable player in the Global Psoriasis Treatment Market, ensuring a competitive edge through continuous innovation and widespread geographical reach.

Key Companies in the Psoriasis Treatment Market Include:

• Pfizer


• MerckandCo


• AbbVie


• JohnsonandJohnson


• Lilly


• GSK


• UCB


• Celgene


• Novartis


• Regeneron Pharmaceuticals


• BristolMyers Squibb


• AstraZeneca


• Amgen


• Eli Lilly and Company


• Sanofi

Psoriasis Treatment Market Industry Developments

In recent months, the Global Psoriasis Treatment Market has experienced significant developments, particularly with companies like AbbVie making strides in Research and Development for improved biologic therapies. In September 2023, Pfizer launched a new clinical trial aimed at exploring innovative treatments for moderate to severe psoriasis, showcasing ongoing commitment in this sector. Similarly, in August 2023, Merck announced advancements in their psoriasis portfolio, aimed at enhancing patient outcomes. 

Major companies including Johnson and Johnson and Novartis continue to engage in improving treatment options, while GSK has been actively investing in research to tap into emerging treatment modalities. In terms of mergers and acquisitions, in July 2023, AstraZeneca completed the acquisition of a portfolio from a small biotech company focused on skin diseases, significantly enhancing their capabilities in the psoriasis market. 

Reports indicate that there is growing momentum for biologic therapies, which has led to increased valuations for key players in the market. Over the past two to three years, the industry has witnessed a marked increase in interest and investment, particularly in targeting more effective treatment options for patients, as the demand for innovative solutions continues to rise globally.

Psoriasis Treatment Market Segmentation Insights

• Psoriasis Treatment Market Treatment Type Outlook
  
  
  
  • Topical Treatments
  
  
  • Systemic Treatments
  
  
  • Phototherapy
  
  
  • Biologics
  
  
  
  


• Psoriasis Treatment Market Administration Route Outlook
  
  
  
  • Oral
  
  
  • Topical
  
  
  • Injectable
  
  
  • Intravenous
  
  
  
  


• Psoriasis Treatment Market Indication Outlook
  
  
  
  • Plaque Psoriasis
  
  
  • Guttate Psoriasis
  
  
  • Inverse Psoriasis
  
  
  • Pustular Psoriasis
  
  
  
  


• Psoriasis Treatment Market End User Outlook
  
  
  
  • Hospital
  
  
  • Dermatology Clinics
  
  
  • Homecare Settings
  
  
  
  


• Psoriasis Treatment Market Regional Outlook
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa
  
  
  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	7.14(USD Billion)
MARKET SIZE 2024	7.45(USD Billion)
MARKET SIZE 2035	12.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.43% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Pfizer, Merck and Co, AbbVie, Johnson and Johnson, Lilly, GSK, UCB, Celgene, Novartis, Regeneron Pharmaceuticals, BristolMyers Squibb, AstraZeneca, Amgen, Eli Lilly and Company, Sanofi
SEGMENTS COVERED	Treatment Type, Administration Route, Indication, End User, Regional
KEY MARKET OPPORTUNITIES	Increasing prevalence of psoriasis, Growing demand for biologics, Expansion of telemedicine solutions, Advancements in personalized medicine, Rising awareness and education initiatives
KEY MARKET DYNAMICS	rising prevalence of psoriasis, increasing demand for biologics, advancements in treatment technologies, growing awareness and education, favorable reimbursement policies
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA